Staphylococcus aureus gene expression in a rat model of infective endocarditis

Genome Medicine

Volumn 6, Issue 11, 2014, Pages

  Hanses, Frank ^a,b   Roux, Christelle ^c   Dunman, Paul M ^c   Salzberger, Bernd ^b   Lee, Jean C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADHESIN; ALCOHOL DEHYDROGENASE; ALPHA HEMOLYSIN; ANTIGEN; CLUMPING FACTOR A; CLUMPING FACTOR B; DELTA HEMOLYSIN; FIBRONECTIN BINDING PROTEIN; FIBRONECTIN BINDING PROTEIN A; GAMMA HEMOLYSIN; GLYCERALDEHYDE; GLYCERALDEHYDE DEHYDROGENASE; HEMOLYSIN; LEUKOCIDIN; MEMBRANE PROTEIN; METALLOPROTEINASE; N ACETYLGLUCOSAMINE; NITRITE REDUCTASE; OXIDOREDUCTASE; POLYSACCHARIDE; PROTEINASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SERINE PROTEINASE; SIDEROPHORE; STAPHYLOCOCCAL SECRETORY ANTIGEN; STAPHYLOCOCCUS ENTEROTOXIN B; SUPEROXIDE DISMUTASE; TOXIN; TRANSCRIPTOME; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CARBOHYDRATE METABOLISM; CARBOHYDRATE TRANSPORT; CONTROLLED STUDY; DELETION MUTANT; DIABETES MELLITUS; DISEASE SEVERITY; GENE EXPRESSION; GLUCOSE METABOLISM; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; OPERON; PATHOGENESIS; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATOR GENE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STAPHYLOFERRIN B OPERON; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UPREGULATION;

EID: 84920778098     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-014-0093-3     Document Type: Article

References (70)

1. Federspiel JJ, Stearns SC, Peppercorn AF, Chu VH, Fowler VG. Increasing US rates of endocarditis with Staphylococcus aureus: 1999-2008. Arch Intern Med 2012, 172:363-365. 10.1001/archinternmed.2011.1027, 22371926.
2. Sy RW, Kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia. Eur Heart J 2010, 31:1890-1897. 10.1093/eurheartj/ehq110, 20453066.
3. Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falco V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009, 169:463-473. 10.1001/archinternmed.2008.603, 19273776.
4. Walpot J, Blok W, van Zwienen J, Klazen C, Amsel B. Incidence and complication rate of infective endocarditis in the Dutch region of Walcheren: a 3-year retrospective study. Acta Cardiol 2006, 61:175-181. 10.2143/AC.61.2.2014331, 16716019.
5. Fowler VG, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005, 293:3012-3021. 10.1001/jama.293.24.3012, 15972563.
6. Kourany WM, Miro JM, Moreno A, Corey GR, Pappas PA, Abrutyn E, Hoen B, Habib G, Fowler VG, Sexton DJ, Olaison L, Cabell CH. Influence of diabetes mellitus on the clinical manifestations and prognosis of infective endocarditis: a report from the International Collaboration on Endocarditis-Merged Database. Scand J Infect Dis 2006, 38:613-619. 10.1080/00365540600617017, 16857604.
7. Delahaye F, Alla F, Beguinot I, Bruneval P, Doco-Lecompte T, Lacassin F, Selton-Suty C, Vandenesch F, Vernet V, Hoen B. In-hospital mortality of infective endocarditis: prognostic factors and evolution over an 8-year period. Scand J Infect Dis 2007, 39:849-857. 10.1080/00365540701393088, 17852900.
8. Rich J, Lee JC. The pathogenesis of Staphylococcus aureus infection in the diabetic NOD mouse. Diabetes 2005, 54:2904-2910. 10.2337/diabetes.54.10.2904, 16186391.
9. Que YA, Haefliger JA, Piroth L, Francois P, Widmer E, Entenza JM, Sinha B, Herrmann M, Francioli P, Vaudaux P, Moreillon P. Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J Exp Med 2005, 201:1627-1635. 10.1084/jem.20050125, 15897276.
10. Moreillon P, Entenza JM, Francioli P, McDevitt D, Foster TJ, Francois P, Vaudaux P. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun 1995, 63:4738-4743. 7591130.
11. Sullam PM, Bayer AS, Foss WM, Cheung AL. Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis. Infect Immun 1996, 64:4915-4921. 8945526.
12. Lee JC, Takeda S, Livolsi PJ, Paoletti LC. Effects of in vitro and in vivo growth conditions on expression of type 8 capsular polysaccharide by Staphylococcus aureus. Infect Immun 1993, 61:1853-1858. 8478074.
13. Cheung AL, Yeaman MR, Sullam PM, Witt MD, Bayer AS. Role of the sar locus of Staphylococcus aureus in induction of endocarditis in rabbits. Infect Immun 1994, 62:1719-1725. 8168933.
14. Bayer AS, Ramos MD, Menzies BE, Yeaman MR, Shen AJ, Cheung AL. Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins. Infect Immun 1997, 65:4652-4660. 9353046.
15. Weiss WJ, Lenoy E, Murphy T, Tardio L, Burgio P, Projan SJ, Schneewind O, Alksne L. Effect of srtA and srtB gene expression on the virulence of Staphylococcus aureus in animal models of infection. J Antimicrob Chemother 2004, 53:480-486. 10.1093/jac/dkh078, 14762051.
16. Bayer AS, Coulter SN, Stover CK, Schwan WR. Impact of the high-affinity proline permease gene (putP) on the virulence of Staphylococcus aureus in experimental endocarditis. Infect Immun 1999, 67:740-744. 9916085.
17. Ding Y, Onodera Y, Lee JC, Hooper DC. NorB, an efflux pump in Staphylococcus aureus strain MW2, contributes to bacterial fitness in abscesses. J Bacteriol 2008, 190:7123-7129. 10.1128/JB.00655-08, 18723624.
18. Goerke C, Fluckiger U, Steinhuber A, Bisanzio V, Ulrich M, Bischoff M, Patti JM, Wolz C. Role of Staphylococcus aureus global regulators sae and sigmaB in virulence gene expression during device-related infection. Infect Immun 2005, 73:3415-3421. 10.1128/IAI.73.6.3415-3421.2005, 15908369.
19. Chaffin DO, Taylor D, Skerrett SJ, Rubens CE. Changes in the Staphylococcus aureus transcriptome during early adaptation to the lung. PLoS One 2012, 7:e41329. 10.1371/journal.pone.0041329, 22876285.
20. Date SV, Modrusan Z, Lawrence M, Morisaki JH, Toy K, Shah IM, Kim J, Park S, Xu M, Basuino L, Chan L, Zeitschel D, Chambers HF, Tan M-W, Brown EJ, Diep BA, Hazenbos WLW. Global gene expression of methicillin-resistant Staphylococcus aureus USA300 during human and mouse infection. J Infect Dis 2014, 209:1542-1550. 10.1093/infdis/jit668, 24286981.
21. Pragman AA, Schlievert PM. Virulence regulation in Staphylococcus aureus: the need for in vivo analysis of virulence factor regulation. FEMS Immunol Med Microbiol 2004, 42:147-154. 10.1016/j.femsim.2004.05.005, 15364098.
22. O'Brien L, Kerrigan SW, Kaw G, Hogan M, Penadés J, Litt D, Fitzgerald DJ, Foster TJ, Cox D. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol Microbiol 2002, 44:1033-1044. 10.1046/j.1365-2958.2002.02935.x, 12010496.
23. Dale SE, Doherty-Kirby A, Lajoie G, Heinrichs DE. Role of siderophore biosynthesis in virulence of Staphylococcus aureus: identification and characterization of genes involved in production of a siderophore. Infect Immun 2004, 72:29-37. 10.1128/IAI.72.1.29-37.2004, 14688077.
24. Alba-Loureiro TC, Hirabara SM, Mendonca JR, Curi R, Pithon-Curi TC. Diabetes causes marked changes in function and metabolism of rat neutrophils. J Endocrinol 2006, 188:295-303. 10.1677/joe.1.06438, 16461555.
25. Lee JC, Park JS, Shepherd SE, Carey V, Fattom A. Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats. Infect Immun 1997, 65:4146-4151. 9317020.
26. Beenken KE, Dunman PM, McAleese F, Macapagal D, Murphy E, Projan SJ, Blevins JS, Smeltzer MS. Global gene expression in Staphylococcus aureus biofilms. J Bacteriol 2004, 186:4665-4684. 10.1128/JB.186.14.4665-4684.2004, 15231800.
27. Dale SE, Sebulsky MT, Heinrichs DE. Involvement of SirABC in iron-siderophore import in Staphylococcus aureus. J Bacteriol 2004, 186:8356-8362. 10.1128/JB.186.24.8356-8362.2004, 15576785.
28. Beasley FC, Vines ED, Grigg JC, Zheng Q, Liu S, Lajoie GA, Murphy ME, Heinrichs DE. Characterization of staphyloferrin A biosynthetic and transport mutants in Staphylococcus aureus. Mol Microbiol 2009, 72:947-963. 10.1111/j.1365-2958.2009.06698.x, 19400778.
29. Ding Y, Fu Y, Lee JC, Hooper DC. Staphylococcus aureus NorD, a putative efflux pump coregulated with the Opp1 oligopeptide permease, contributes selectively to fitness in vivo. J Bacteriol 2012, 194:6586-6593. 10.1128/JB.01414-12, 23042988.
30. Kehl-Fie TE, Zhang Y, Moore JL, Farrand AJ, Hood MI, Rathi S, Chazin WJ, Caprioli RM, Skaar EP. MntABC and MntH contribute to systemic Staphylococcus aureus infection by competing with calprotectin for nutrient manganese. Infect Immun 2013, 81:3395-3405. 10.1128/IAI.00420-13, 23817615.
31. Procopio Evagrio George N, Wei Q, Kyun Shin P, Konstantopoulos K, Ross JM. Staphylococcus aureus adhesion via Spa, ClfA, and SdrCDE to immobilized platelets demonstrates shear-dependent behavior. Arterioscler Thromb Vasc Biol 2006, 26:2394-2400. 10.1161/01.ATV.0000237606.90253.94.
32. Palazzolo-Ballance AM, Reniere ML, Braughton KR, Sturdevant DE, Otto M, Kreiswirth BN, Skaar EP, DeLeo FR. Neutrophil microbicides induce a pathogen survival response in community-associated methicillin-resistant Staphylococcus aureus. J Immunol 2008, 180:500-509. 10.4049/jimmunol.180.1.500, 18097052.
33. Weinrick B, Dunman PM, McAleese F, Murphy E, Projan SJ, Fang Y, Novick RP. Effect of mild acid on gene expression in Staphylococcus aureus. J Bacteriol 2004, 186:8407-8423. 10.1128/JB.186.24.8407-8423.2004, 15576791.
34. Resch A, Rosenstein R, Nerz C, Gotz F. Differential gene expression profiling of Staphylococcus aureus cultivated under biofilm and planktonic conditions. Appl Environ Microbiol 2005, 71:2663-2676. 10.1128/AEM.71.5.2663-2676.2005, 15870358.
35. Malachowa N, Whitney AR, Kobayashi SD, Sturdevant DE, Kennedy AD, Braughton KR, Shabb DW, Diep BA, Chambers HF, Otto M, DeLeo FR. Global changes in Staphylococcus aureus gene expression in human blood. PLoS One 2011, 6:e18617. 10.1371/journal.pone.0018617, 21525981.
36. Voyich JM, Braughton KR, Sturdevant DE, Whitney AR, Said-Salim B, Porcella SF, Long RD, Dorward DW, Gardner DJ, Kreiswirth BN, Musser JM, DeLeo FR. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 2005, 175:3907-3919. 10.4049/jimmunol.175.6.3907, 16148137.
37. Diep BA, Palazzolo-Ballance AM, Tattevin P, Basuino L, Braughton KR, Whitney AR, Chen L, Kreiswirth BN, Otto M, DeLeo FR, Chambers HF. Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS One 2008, 3:e3198. 10.1371/journal.pone.0003198, 18787708.
38. Pohl K, Francois P, Stenz L, Schlink F, Geiger T, Herbert S, Goerke C, Schrenzel J, Wolz C. CodY in Staphylococcus aureus: a regulatory link between metabolism and virulence gene expression. J Bacteriol 2009, 191:2953-2963. 10.1128/JB.01492-08, 19251851.
39. Baba T, Bae T, Schneewind O, Takeuchi F, Hiramatsu K. Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J Bacteriol 2008, 190:300-310. 10.1128/JB.01000-07, 17951380.
40. Grundmeier M, Hussain M, Becker P, Heilmann C, Peters G, Sinha B. Truncation of fibronectin-binding proteins in Staphylococcus aureus strain Newman leads to deficient adherence and host cell invasion due to loss of the cell wall anchor function. Infect Immun 2004, 72:7155-7163. 10.1128/IAI.72.12.7155-7163.2004, 15557640.
41. Geiger T, Goerke C, Mainiero M, Kraus D, Wolz C. The virulence regulator Sae of Staphylococcus aureus: promoter activities and response to phagocytosis-related signals. J Bacteriol 2008, 190:3419-3428. 10.1128/JB.01927-07, 18344360.
42. Herbert S, Ziebandt AK, Ohlsen K, Schafer T, Hecker M, Albrecht D, Novick R, Gotz F. Repair of global regulators in Staphylococcus aureus 8325 and comparative analysis with other clinical isolates. Infect Immun 2010, 78:2877-2889. 10.1128/IAI.00088-10, 20212089.
43. Wolz C, Goerke C, Landmann R, Zimmerli W, Fluckiger U. Transcription of clumping factor A in attached and unattached Staphylococcus aureus in vitro and during device-related infection. Infect Immun 2002, 70:2758-2762. 10.1128/IAI.70.6.2758-2762.2002, 12010960.
44. Schennings T, Heimdahl A, Coster K, Flock JI. Immunization with fibronectin binding protein from Staphylococcus aureus protects against experimental endocarditis in rats. Microb Pathog 1993, 15:227-236. 10.1006/mpat.1993.1073, 8271922.
45. Siboo IR, Cheung AL, Bayer AS, Sullam PM. Clumping factor A mediates binding of Staphylococcus aureus to human platelets. Infect Immun 2001, 69:3120-3127. 10.1128/IAI.69.5.3120-3127.2001, 11292731.
46. Baddour LM, Lowrance C, Albus A, Lowrance JH, Anderson SK, Lee JC. Staphylococcus aureus microcapsule expression attenuates bacterial virulence in a rat model of experimental endocarditis. J Infect Dis 1992, 165:749-753. 10.1093/infdis/165.4.749, 1552206.
47. Watts A, Ke D, Wang Q, Pillay A, Nicholson-Weller A, Lee JC. Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence. Infect Immun 2005, 73:3502-3511. 10.1128/IAI.73.6.3502-3511.2005, 15908379.
48. Wacker M, Wang L, Kowarik M, Dowd M, Lipowsky G, Faridmoayer A, Shields K, Park S, Alaimo C, Kelley KA, Braun M, Quebatte J, Gambillara V, Carranza P, Steffen M, Lee JC. Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli. J Infect Dis 2014, 209:1551-1561. 10.1093/infdis/jit800, 24308931.
49. Koprivnjak T, Mlakar V, Swanson L, Fournier B, Peschel A, Weiss JP. Cation-induced transcriptional regulation of the dlt operon of Staphylococcus aureus. J Bacteriol 2006, 188:3622-3630. 10.1128/JB.188.10.3622-3630.2006, 16672616.
50. Yang S-J, Kreiswirth BN, Sakoulas G, Yeaman MR, Xiong YQ, Sawa A, Bayer AS. Enhanced expression of dltABCD Is associated with the development of daptomycin nonsusceptibility in a clinical endocarditis isolate of Staphylococcus aureus. J Infect Dis 2009, 200:1916-1920. 10.1086/648473, 19919306.
51. Levine DP, Lamp KC. Daptomycin in the treatment of patients with infective endocarditis: experience from a registry. Am J Med 2007, 120:S28-S33. 10.1016/j.amjmed.2007.07.011, 17904948.
52. Sakoulas G, Eliopoulos GM, Alder J, Eliopoulos CT. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2003, 47:1714-1718. 10.1128/AAC.47.5.1714-1718.2003, 12709345.
53. Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 2004, 48:4673-4679. 10.1128/AAC.48.12.4673-4679.2004, 15561843.
54. Boles BR, Horswill AR. Agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS Pathog 2008, 4:e1000052. 10.1371/journal.ppat.1000052, 18437240.
55. Kaneko J, Kamio Y. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Biosci Biotechnol Biochem 2004, 68:981-1003. 10.1271/bbb.68.981, 15170101.
56. Cheung J, Beasley FC, Liu S, Lajoie GA, Heinrichs DE. Molecular characterization of staphyloferrin B biosynthesis in Staphylococcus aureus. Mol Microbiol 2009, 74:594-608. 10.1111/j.1365-2958.2009.06880.x, 19775248.
57. Skaar EP, Humayun M, Bae T, DeBord KL, Schneewind O. Iron-source preference of Staphylococcus aureus infections. Science 2004, 305:1626-1628. 10.1126/science.1099930, 15361626.
58. Speziali CD, Dale SE, Henderson JA, Vines ED, Heinrichs DE. Requirement of Staphylococcus aureus ATP-binding cassette-ATPase FhuC for iron-restricted growth and evidence that it functions with more than one iron transporter. J Bacteriol 2006, 188:2048-2055. 10.1128/JB.188.6.2048-2055.2006, 16513734.
59. Mishra R, Mariotti P, Fiaschi L, Nosrai S, Maccari S, Liberatori S, Fontana M, Pezzicoli A, De Falco M, Falugi F, Altindis E, Serruto D, Grandi G, Bagnoli F. Staphylococcus aureus FhuD2 is involved in the early phase of staphylococcal dissemination and generates protective immunity in mice. J Infect Dis 2012, 206:1041-1049. 10.1093/infdis/jis463, 22829645.
60. Truong-Bolduc QC, Hsing LC, Villet R, Bolduc GR, Estabrooks Z, Taguezem GF, Hooper DC. Reduced aeration affects the expression of the NorB efflux pump of Staphylococcus aureus by posttranslational modification of MgrA. J Bacteriol 2012, 194:1823-1834. 10.1128/JB.06503-11, 22287526.
61. Sitkiewicz I, Babiak I, Hryniewicz W. Characterization of transcription within sdr region of Staphylococcus aureus. Antonie Van Leeuwenhoek 2011, 99:409-416. 10.1007/s10482-010-9476-7, 20571861.
62. Barbu EM, Ganesh VK, Gurusiddappa S, Mackenzie RC, Foster TJ, Sudhof TC, Höök M. β-Neurexin is a ligand for the Staphylococcus aureus MSCRAMM SdrC. PLoS Pathog 2010, 6:e1000726. 10.1371/journal.ppat.1000726, 20090838.
63. Makhlin J, Kofman T, Borovok I, Kohler C, Engelmann S, Cohen G, Aharonowitz Y. Staphylococcus aureus ArcR controls expression of the arginine deiminase operon. J Bacteriol 2007, 189:5976-5986. 10.1128/JB.00592-07, 17557828.
64. Leibig M, Liebeke M, Mader D, Lalk M, Peschel A, Götz F. Pyruvate formate lyase acts as a formate supplier for metabolic processes during anaerobiosis in Staphylococcus aureus. J Bacteriol 2011, 193:952-962. 10.1128/JB.01161-10, 21169491.
65. Ballal A, Manna AC. Regulation of superoxide dismutase (sod) Genes by SarA in Staphylococcus aureus. J Bacteriol 2009, 191:3301-3310. 10.1128/JB.01496-08, 19286803.
66. Xiong YQ, Van Wamel W, Nast CC, Yeaman MR, Cheung AL, Bayer AS. Activation and transcriptional interaction between agr RNAII and RNAIII in Staphylococcus aureus in vitro and in an experimental endocarditis model. J Infect Dis 2002, 186:668-677. 10.1086/342046, 12195354.
67. Torres VJ, Attia AS, Mason WJ, Hood MI, Corbin BD, Beasley FC, Anderson KL, Stauff DL, McDonald WH, Zimmerman LJ, Friedman DB, Heinrichs DE, Dunman PM, Skaar EP. Staphylococcus aureus Fur regulates the expression of virulence factors that contribute to the pathogenesis of pneumonia. Infect Immun 2010, 78:1618-1628. 10.1128/IAI.01423-09, 20100857.
68. Pietiainen M, Francois P, Hyyrylainen HL, Tangomo M, Sass V, Sahl HG, Schrenzel J, Kontinen VP. Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance. BMC Genomics 2009, 10:429. 10.1186/1471-2164-10-429, 19751498.
69. Yang J, Tauschek M, Robins-Browne RM. Control of bacterial virulence by AraC-like regulators that respond to chemical signals. Trends Microbiol 2011, 19:128-135. 10.1016/j.tim.2010.12.001, 21215638.
70. Seidl K, Muller S, Francois P, Kriebitzsch C, Schrenzel J, Engelmann S, Bischoff M, Berger-Bachi B. Effect of a glucose impulse on the CcpA regulon in Staphylococcus aureus. BMC Microbiol 2009, 9:95. 10.1186/1471-2180-9-95, 19450265.